These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 17091603

  • 21. [Advances in the study of mechanisms of the tumor angiogenesis inhibitors].
    Xiao D, Ding J.
    Sheng Li Ke Xue Jin Zhan; 1999 Jul; 30(3):219-23. PubMed ID: 12532783
    [Abstract] [Full Text] [Related]

  • 22. Chapter 14. Measuring intratumoral microvessel density.
    Weidner N.
    Methods Enzymol; 2008 Jul; 444():305-23. PubMed ID: 19007671
    [Abstract] [Full Text] [Related]

  • 23. Involvement of RB gene family in tumor angiogenesis.
    Gabellini C, Del Bufalo D, Zupi G.
    Oncogene; 2006 Aug 28; 25(38):5326-32. PubMed ID: 16936754
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Chapter 11. The role of bone marrow-derived cells in tumor angiogenesis and metastatic progression.
    Papaspyridonos M, Lyden D.
    Methods Enzymol; 2008 Aug 28; 444():255-69. PubMed ID: 19007668
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Tumour vascularisation: a druggable target.
    Bishop-Bailey D.
    Curr Opin Pharmacol; 2009 Apr 28; 9(2):96-101. PubMed ID: 19056315
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Interleukin-1alpha enhances angiogenesis and is associated with liver metastatic potential in human gastric cancer cell lines.
    Ma J, Sawai H, Matsuo Y, Ochi N, Yasuda A, Takahashi H, Wakasugi T, Funahashi H, Sato M, Okada Y, Takeyama H, Manabe T.
    J Surg Res; 2008 Aug 28; 148(2):197-204. PubMed ID: 18395750
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Understanding the biology of angiogenesis: review of the most important molecular mechanisms.
    Otrock ZK, Mahfouz RA, Makarem JA, Shamseddine AI.
    Blood Cells Mol Dis; 2007 Aug 28; 39(2):212-20. PubMed ID: 17553709
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Tumoral angiogenesis: review of the literature.
    Khosravi Shahi P, Fernández Pineda I.
    Cancer Invest; 2008 Feb 28; 26(1):104-8. PubMed ID: 18181052
    [Abstract] [Full Text] [Related]

  • 36. Mathematical modeling of tumor-induced angiogenesis.
    Chaplain MA, McDougall SR, Anderson AR.
    Annu Rev Biomed Eng; 2006 Feb 28; 8():233-57. PubMed ID: 16834556
    [Abstract] [Full Text] [Related]

  • 37. Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds.
    Cuevas I, Boudreau N.
    Adv Cancer Res; 2009 Feb 28; 103():25-42. PubMed ID: 19854351
    [Abstract] [Full Text] [Related]

  • 38. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A, Nakagawa K, Sookwong P, Tsuzuki T, Oikawa S, Miyazawa T.
    Biochem Pharmacol; 2008 Aug 01; 76(3):330-9. PubMed ID: 18599020
    [Abstract] [Full Text] [Related]

  • 39. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F, Ferrara N.
    Drug Resist Updat; 2008 Dec 01; 11(6):219-30. PubMed ID: 18948057
    [Abstract] [Full Text] [Related]

  • 40. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.